跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
高特灵 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Terazosin Hydrochloride Tablets
Approved
化学药品
Terazosin Hydrochloride Tablets
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jul 22, 2021
Approval ID
8BYsXX2uEXF
Company
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Type
化学药品
Approval Details
Approval Id
8BYsXX2uEXF
Approval Number
国药准字HJ20181009
Generic Name
盐酸特拉唑嗪片
Generic Name En
Terazosin Hydrochloride Tablets
Trade Name
高特灵
Brand Name
高特灵
Drug Type
化学药品
Dosage Form
片剂
Strength
2mg
Reg Date
2021-07-22
Expired Date
2026-07-21
Company Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Production Company Name
AESICA QUEENBOROUGH LIMITED
Company Detail Path
/organization/abbott-laboratories-singapore-private-limited
Production Company Detail Path
/organization/aesica-queenborough-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 22, 2021
Approval ID
8BYsXX2uEXF
Type
化学药品
Back to NMPA Approvals